Obtenga las últimas noticias sobre las acciones de Bioventus con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de BVS

Últimas noticias sobre

Bioventus

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Long Ideas

News

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

GWRS

Compras recientes de insiders en Bioventus, W.P. Carey y Global Water Resources. ¿Indican estas adquisiciones una oportunidad en el mercado?

Compras de acciones de Bioventus, W. P. Carey y Global Water Resources: Insider Trading

Bioventus Inc

BRAVURA SOLUTIONS LTD by Bravura Solutions Ltd.

Bravura Solutions Ltd

BMO ASIA USD INVST GR by BMO Asia USD Investment Grade Bond ETF

Press Releases

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

Earnings

Bioventus Reports First Quarter Financial Results

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

Health Care

General

Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products

Financing

Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity

Bioventus Reports Second Quarter Financial Results

Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference

Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights

Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025

Alcon

Align Technology

Avanos Medical

Bausch & Lomb

Cerus

The Cooper Companies, Inc. - Common Stock

Cooper Companies

Embecta

Establishment Labs Holdings Inc. - Common Shares

Establishment Labs Hldgs

Haemonetics

ICU Medical

OrthoPediatrics

Lantheus Holdings

Merit Medical Systems, Inc. - Common Stock

Merit Medical Systems

Neogen

InspireMD

OraSure Technologies, Inc. - Common Stock

OraSure Technologies

RxSight

Sanara MedTech

Solventum

Staar Surgical

Sharps Technology

UFP Technologies

Utah Medical Products, Inc. - Common Stock

Utah Medical Products

Dentsply Sirona

Xtant Medical Holdings, Inc. Common Stock

Xtant Medical Hldgs

Cantor Fitzgerald

Canaccord Genuity

JP Morgan

Craig-Hallum

Comments

Bioventus Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL